Cambodian PM gets AstraZeneca COVID-19 shot, defends Chinese vaccine

PHNOM PENH – Cambodian Prime Minister Hun Sen received on Thursday a shot of the AstraZeneca COVID-19 vaccine supplied by India, about three weeks into the launch of his country’s inoculation programme, which initially relied only on Chinese vaccines.

Mr. Hun Sen, 68, had vowed to be the first to receive the Sinopharm vaccine donated by China, but later said he was too old. His sons and the justice and environment ministers were among the first to get it instead.

China is one of Cambodia’s closest allies, and Hun Sen dismissed public hesitance about the safety of the Sinopharm vaccine.

“The Chinese vaccine has gone to more countries than the AstraZeneca vaccine, even countries that are allies of the West also use the Chinese vaccines,” Mr. Hun Sen told a news conference after getting his shot.

He urged people below 60 to get the Sinopharm vaccine and those older than 60 to receive the AstraZeneca vaccine.


The Southeast Asian nation of about 16 million has reported among the lowest number of coronavirus cases and no deaths, though last month saw a rise in cases that took the cumulative total detected to 909.

Cambodia received its first batch of 324,000 doses of the India-made AstraZeneca vaccine and supplied through the World Health Organization-backed COVAX vaccine-sharing programme on Tuesday.

India and China have been engaged in vaccine diplomacy to bolster their standing in the region, with both donating shipments to smaller and poor countries.

China’s first consignment of 600,000 doses of the Sinopharm vaccine had arrived in Phnom Penh on Feb. 7 and an additional 400,000 doses are set to arrive in April. – Reuters


Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Your daily news source covering investing ideas, market stocks, business, retirement tips from Wall St. to Silicon Valley.

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 TheProficientInvestor. All Rights Reserved.

To Top
Get In-depth Understanding Of The Stock Markets With The Top Headlines Emailed Directly To You Every Day.
We follow a strict anti-spam policy. You may cancel your subscription at any time.